Biotech

All Articles

Eli Lilly hops deeper in to AI along with $409M Genetic Leap offer

.Eli Lilly has vaulted in to an AI-enabled drug discovery deal, partnering along with RNA expert Gen...

After FDA rejection and discharges, Lykos CEO is actually leaving

.Lykos CEO and also owner Amy Emerson is actually stepping down, with chief functioning police offic...

Novartis fires up new stage of Voyager pact along with $15M capsid bargain

.Novartis levels a brand new frontier in its own cooperation along with Voyager Therapeutics, spendi...

Lilly messages extra positive data on its own weekly the hormone insulin possibility

.On the heels of an FDA rejection for its chief competing Novo Nordisk, Eli Lilly is picking up spee...

IN 8bio stops stage 2 trial, gives up half of workforce

.Just a few months after application the very first client in a phase 2 test for newly diagnosed gli...

Lilly, Haya ink $1B biobuck excessive weight contract to search dark genome

.Eli Lilly's look for excessive weight aim ats has actually led it to the darker genome. The Big Pha...

ArsenalBio elevates $325M, pivots away from former lead possession

.Collection Biosciences is actually moving on up. The cell therapy business has actually added $325 ...

Lilly- backed fat loss biotech files IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually sub...

Aelis' cannabis make use of drug flunks phase 2b, steering Indivior to rethink $100M possibility

.Aelis Farma's chances of getting a quick, favorable selection on a $one hundred million choice remi...

ProKidney stops stage 3 trial not required for cell therapy permission

.ProKidney has stopped among a pair of stage 3 trials for its tissue treatment for renal ailment aft...